LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT06479759 · UNKNOWN
Trial details
- NCT number
- NCT06479759
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-12
- Primary completion
- 2025-06-12
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.